Smith & Nephew (SNN) Total Non-Current Liabilities (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Total Non-Current Liabilities of $3.6 billion for Q4 2025, little changed year-on-year from $3.6 billion in Q4 2024, and down 29.42% on a QoQ basis from $5.1 billion in Q2 2025.
Smith & Nephew (SNN) Total Non-Current Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.6 billion the latest figure, recorded in Q4 2025.
- Quarterly Total Non-Current Liabilities changed 0.42% year-over-year to $3.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 billion (changed 0.42% YoY) and the FY2025 annual result came in at $3.6 billion, changed 0.42% from the prior year.
- Total Non-Current Liabilities eased to $3.6 billion in Q4 2025 per SNN's latest filing, from $5.1 billion in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for SNN reached as high as $5.2 billion in Q2 2024 and fell as low as $2.5 billion in Q4 2023.
- A 5-year average of $3.7 billion and a median of $3.6 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities slipped 20.37% — and 2024, when it jumped 42.38%.
- Year by year, Total Non-Current Liabilities stood at $3.2 billion in 2021, then retreated by 7.11% to $3.0 billion in 2022, then fell by 16.48% to $2.5 billion in 2023, then jumped by 42.38% to $3.6 billion in 2024, then gained by 0.42% to $3.6 billion in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.6 billion, $5.1 billion, and $3.6 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 3.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.57 Bn |
| Jun 28, 2025 | 5.06 Bn |
| Dec 31, 2024 | 3.56 Bn |
| Jun 29, 2024 | 5.19 Bn |
| Dec 31, 2023 | 2.50 Bn |
| Dec 31, 2022 | 2.99 Bn |
| Dec 31, 2021 | 3.22 Bn |
| Dec 31, 2020 | 4.05 Bn |
| Jun 30, 2020 | 4.34 Bn |
| Dec 31, 2019 | 2.59 Bn |
| Jun 29, 2019 | 3.85 Bn |
| Dec 31, 2018 | 1.72 Bn |
| Jun 30, 2018 | 2.93 Bn |
| Dec 31, 2017 | 1.88 Bn |
| Dec 31, 2016 | 2.04 Bn |
| Dec 31, 2015 | 1.86 Bn |
| Jun 30, 2015 | 1.94 Bn |
| Dec 31, 2014 | 2.10 Bn |
| Sep 30, 2014 | 3.55 Bn |
| Jun 28, 2014 | 2.44 Bn |